This Week in Oncology with Punit Dhillion

JustOncology

JustOncology

Call in to speak with the host

(818) 337-0007

On the Wednesday, April 18th, 2012 broadcast, at 1:30PM Pacific and 4:30Eastern time, our special guest is Punit Dhillion, co-founder, President and Chief Executive Officer of OncoSec Medical Incorporated.

 

OncoSec Medical Inc (OTC BB: ONCS) is developing novel, localized anti-cancer therapies against solid tumors to overcome the significant cosmetic, functional and other side effects associated with surgery and other non-targeted therapeutic approaches.
 
Oncosec’s minimally invasive therapies use electrical stimulation known as electroporation to significantly increase the entry of anti-cancer chemotherapeutic or biologic agents into cells of selectively targeted tumors and tissue. These treatments selectively destroy cancer cells while preserving healthy tissue. They optimize required dosage and potentially reduce treatment and post-treatment costs. 
 
OncoSec is advancing its novel anti-cancer therapies into advanced stage clinical trials.

For more information click here.

Please join us for an exciting exploration of the promising world of cancer research.

Tags:
oncology
cancer care
cancer research
oncosec
social media
Broadcast in Health
h:210699
s:3088427
archived

Comments

 comments